Literature DB >> 11131462

The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy.

T Stroffolini1, A Mele, M E Tosti, G Gallo, E Balocchini, P Ragni, F Santonastasi, A Marzolini, M Ciccozzi, A Moiraghi.   

Abstract

BACKGROUND/AIMS: This study aimed to evaluate the impact of the campaign for hepatitis B mass immunisation of children and teenagers, introduced in 1991, on the incidence of and risk factors for hepatitis B in Italy.
METHODS: Hepatitis B cases reported to the surveillance system for type-specific acute viral hepatitis (SEIEVA) during the period 1987-1997 were used to estimate incidence. To assess the association between potential risk factors and hepatitis B cases, hepatitis A cases generated by the same surveillance system were used as controls.
RESULTS: During the period 1987-1997, 8275 acute hepatitis B cases were reported to SEIEVA. Hepatitis B incidence declined from 10.4/100,000 in 1987 to 2.9/100,000 in 1997. The fall was more evident before than after the introduction of compulsory vaccination against hepatitis B. The results of multivariate analysis showed that during the years 1995-1997, blood transfusion, intravenous drug use, surgical intervention, dental therapy, other parenteral exposures, multiple sexual partners, and being in the household of a chronic HBsAg carrier were all exposures independently associated with hepatitis B.
CONCLUSIONS: The strong association linking acute hepatitis B with iatrogenic exposures, which are more common in adults, suggests that the present immunisation strategy should be combined with the implementation of non-immunologic preventive measures.

Entities:  

Mesh:

Year:  2000        PMID: 11131462     DOI: 10.1016/s0168-8278(00)80132-4

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  22 in total

1.  Presence of anti-HBs antibodies in blood donors 18-22 years after vaccination and implications for the selection of candidates for plasmapheresis for the production of hyperimmune plasma.

Authors:  Massimo De Paschale; Stefania Latella; Arianna Gatti; Bruno Brando; M Teresa Manco; Luisa Belvisi; Debora Cagnin; Teresa Cerulli; Alessia Paganini; Maurizio Macchi; Pierangelo Clerici
Journal:  Blood Transfus       Date:  2015-10-29       Impact factor: 3.443

2.  HBV Infection Among HIV-Infected Cohort and HIV-Negative Hospital Attendees in South Western Nigeria.

Authors:  Moses Olubusuyi Adewumi; Emmanuel Donbraye; Waidi Folorunso Sule; Olaniran Olarinde
Journal:  Afr J Infect Dis       Date:  2015

Review 3.  Emerging drugs for hepatitis B.

Authors:  Fabien Zoulim
Journal:  Expert Opin Emerg Drugs       Date:  2007-05       Impact factor: 4.191

4.  Long-term persistence of immunity after hepatitis B vaccination: Is this substantiated by the literature?

Authors:  Terence T Lao
Journal:  Hum Vaccin Immunother       Date:  2017-03-01       Impact factor: 3.452

5.  Prevalence of markers of hepatitis B virus infection or vaccination in HBsAg-negative subjects.

Authors:  Massimo De Paschale; Maria Teresa Manco; Luisa Belvisi; Bruno Brando; Stefania Latella; Carlo Agrappi; Paola Mirri; Arianna Gatti; Pierangelo Clerici
Journal:  Blood Transfus       Date:  2012-04-13       Impact factor: 3.443

6.  Long-term persistence of immunity after hepatitis B vaccination: A fact, not a fancy.

Authors:  Andrea Trevisan
Journal:  Hum Vaccin Immunother       Date:  2016-12-01       Impact factor: 3.452

7.  Impact of hepatitis B vaccination in children born to HBsAg-positive mothers: a 20-year retrospective study.

Authors:  L Bracciale; M Fabbiani; A Sansoni; L Luzzi; L Bernini; G Zanelli
Journal:  Infection       Date:  2009-07-23       Impact factor: 3.553

8.  Acute hepatitis B in the era of immunisation: pitfalls in the identification of high risk patients.

Authors:  G Rosner; Y Lurie; L Blendis; Z Halpern; R Oren
Journal:  Postgrad Med J       Date:  2006-03       Impact factor: 2.401

9.  Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study.

Authors:  M Fasano; A Saracino; G Carosi; F Mazzotta; N Marino; E Sagnelli; G B Gaeta; G Angarano; G Verucchi; P Bellissima; C Angeletti; T Santantonio
Journal:  Infection       Date:  2012-12-21       Impact factor: 3.553

Review 10.  Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy.

Authors:  Evangelista Sagnelli; Caterina Sagnelli; Mariantonietta Pisaturo; Margherita Macera; Nicola Coppola
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.